CIBC Private Wealth Group’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.78K | Sell |
46
-13
| -22% | -$1.63K | ﹤0.01% | 2424 |
|
|
2025
Q1 | $5.17K | Sell |
59
-986
| -94% | -$86.3K | ﹤0.01% | 2444 |
|
|
2024
Q4 | $145K | Sell |
1,045
-107
| -9% | -$14.8K | ﹤0.01% | 1285 |
|
|
2024
Q3 | $133K | Sell |
1,152
-3
| -0.3% | -$346 | ﹤0.01% | 1369 |
|
|
2024
Q2 | $164K | Sell |
1,155
-6,472
| -85% | -$921K | ﹤0.01% | 1198 |
|
|
2024
Q1 | $1.08M | Buy |
+7,627
| New | +$1.08M | ﹤0.01% | 658 |
|
|
2023
Q1 | – | Sell |
-24,925
| Closed | -$2.98K | – | 919 |
|
|
2022
Q4 | $2.98K | Buy |
24,925
+3,846
| +18% | +$459 | ﹤0.01% | 748 |
|
|
2022
Q3 | $2.24M | Buy |
+21,079
| New | +$2.24M | 0.01% | 464 |
|